Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference

Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference

PR Newswire

ATLANTA, May 22, 2018 /PRNewswire/ -- Alimera Sciences ALIM, a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that CEO Dan Myers will be presenting at the 8th annual LD Micro Invitational Conference taking place June 4-6, 2018 at the Luxe Sunset hotel in Bel-Air, California.

The Company's presentation will take place on June 5th at 8:30 AM and a webcast will be available on the Company's website at www.alimerasciences.com.

About Alimera Sciences, Inc.

www.alimerasciences.com

Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product portfolio. For more information, please visit www.alimerasciences.com.

For press inquiries:

Katie Brazel

for Alimera Sciences

404-317-8361

kbrazel@bellsouth.net

For investor inquiries:

CG Capital

for Alimera Sciences

877-889-1972

investorrelations@cg.capital

 

Cision View original content:http://www.prnewswire.com/news-releases/alimera-sciences-to-present-at-the-8th-annual-ld-micro-invitational-conference-300652295.html

SOURCE Alimera Sciences, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releasestrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!